4.73 USD
↘ 0.12 (2.47%)LIVE (AS OF 02:52 PM EDT)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
Market: OPEN
Open?$4.85
High?$5.06
Low?$4.72
Prev. Close?$4.85
Volume?29.7K
Avg. Volume?57.4K
VWAP?$4.80
Rel. Volume?0.52x
Bid / Ask
Bid?$4.73 × 100
Ask?$5.43 × 100
Spread?$0.70
Midpoint?$5.08
Valuation & Ratios
Market Cap?41.8M
Shares Out?8.6M
Float?7.7M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.37
EPS?-$4.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Themes
Employees
14
Market Cap
41.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.90Strong
Quick Ratio?4.50Strong
Cash Ratio?4.25Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.37CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-123.5%WEAK▾
ROA?-99.2%WEAK▾
Cash Flow & Enterprise
FCF?$-33398000
Enterprise Value?$10.0M
Fundamentals ratios updated end of day